Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)
China · Delayed Price · Currency is CNY 37.77
-1.95 (-4.91%)
At close: Aug 24, 2026
SHA:603102 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,352 | 2,702 | 2,211 | 2,482 | 2,598 | - | |
Market Cap Growth | -14.22% | 22.24% | -10.93% | -4.46% | - | - |
Enterprise Value | 1,229 | 1,685 | 1,133 | 1,407 | 1,565 | - |
Last Close Price | 37.77 | 42.97 | 34.49 | 37.27 | 38.47 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.61 | 21.04 | 15.87 | 14.68 | 18.85 | - |
PS Ratio | 2.37 | 2.97 | 2.76 | 2.85 | 3.58 | - |
PB Ratio | 1.35 | 1.60 | 1.38 | 1.64 | 1.83 | - |
P/TBV Ratio | 1.44 | 1.72 | 1.42 | 1.69 | 1.86 | - |
P/FCF Ratio | 18.44 | 20.73 | 67.54 | 25.50 | 25.63 | - |
P/OCF Ratio | 13.90 | 14.53 | 17.32 | 12.80 | 16.99 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.24 | 1.85 | 1.41 | 1.62 | 2.16 | - |
EV/EBITDA Ratio | 6.18 | 9.20 | 6.16 | 6.79 | 9.20 | - |
EV/EBIT Ratio | 8.43 | 12.04 | 7.87 | 8.24 | 11.32 | - |
EV/FCF Ratio | 9.63 | 12.93 | 34.61 | 14.46 | 15.44 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.10 | 0.08 | 0.00 | 0.01 | 0.02 | 0.02 |
Debt / FCF Ratio | 0.16 | 0.11 | 0.01 | 0.02 | 0.03 | 0.08 |
Net Debt / Equity Ratio | -0.66 | -0.67 | -0.71 | -0.75 | -0.77 | -0.57 |
Net Debt / EBITDA Ratio | -5.99 | -6.17 | -6.17 | -5.47 | -6.45 | -2.33 |
Net Debt / FCF Ratio | -9.08 | -8.68 | -34.66 | -11.65 | -10.82 | -9.21 |
Asset Turnover | 0.52 | 0.48 | 0.45 | 0.51 | 0.56 | 0.81 |
Inventory Turnover | 5.18 | 4.65 | 4.27 | 4.06 | 3.61 | 4.05 |
Quick Ratio | 6.14 | 5.28 | 6.32 | 5.85 | 5.31 | 2.52 |
Current Ratio | 6.89 | 5.91 | 7.01 | 6.51 | 6.02 | 3.18 |
Return on Equity (ROE) | 7.57% | 8.14% | 8.93% | 11.52% | 12.91% | 22.88% |
Return on Assets (ROA) | 4.72% | 4.64% | 5.07% | 6.29% | 6.70% | 11.71% |
Return on Invested Capital (ROIC) | 20.71% | 23.97% | 29.25% | 42.33% | 38.35% | 54.02% |
Return on Capital Employed (ROCE) | 8.20% | 8.20% | 8.90% | 11.10% | 9.60% | 20.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.04% | 4.75% | 6.30% | 6.81% | 5.31% | - |
FCF Yield | 5.42% | 4.82% | 1.48% | 3.92% | 3.90% | - |
Dividend Yield | 1.89% | 1.75% | 2.17% | 2.01% | 1.56% | - |
Payout Ratio | 39.37% | 36.36% | 33.91% | 22.71% | 23.21% | 9.73% |
Buyback Yield / Dilution | 3.87% | 1.96% | 0.21% | -2.21% | -30.36% | -0.20% |
Total Shareholder Return | 5.76% | 3.70% | 2.39% | -0.20% | -28.80% | -0.20% |